BACE1 and Alzheimer disease: Our findings initially unveiled that miR-212-3p suppresses NLRP3/Caspase-1 signal-induced neuronal pyroptosis through regulating the SP1/BACE1 axis to neuroinflammation in AD and hinted at the role of miR-212-3p as a potential therapeutic and diagnostic target in AD treatment.